Effect of Intradialytic Exercise on Hyperphosphatemia and Malnutrition
Nutrients, 2019 Intradialytic exercise (IDE) is not routinely prescribed in hemodialysis (HD) units despite its potential benefits on patients’ outcomes. This study was the first in the United Arab Emirates to examine the effect of aerobic IDE on hyperphosphatemia ...
N. Salhab +6 more
semanticscholar +1 more source
Veterinary Medicine and Science, Volume 11, Issue 6, November 2025.Schematic representation of the research process. ABSTRACT The transition period covers a period of ±21 days based on the calving day. This period is characterised by marked changes in the endocrine status of the animal, increased nutrient demand of the developing foetus and decreased feed intake.
Mustafa İssi +3 more
wiley +1 more source
Novel Treatments from Inhibition of the Intestinal Sodium–Hydrogen Exchanger 3
International Journal of Nephrology and Renovascular Disease, 2021 Csaba P Kovesdy,1 Adebowale Adebiyi,2 David Rosenbaum,3 Jeffrey W Jacobs,3 L Darryl Quarles1 1Division of Nephrology, University of Tennessee Health Science Center, Memphis, TN, USA; 2Department of Physiology, University of Tennessee Health Science ...
Kovesdy CP +4 more
doaj
Association of Ca×PO4 product with levels of serum C-reactive protein in regular hemodialysis patients. [PDF]
, 2012 INTRODUCTION Numerous studies have attempted to identify risk factors for mortality and morbidity in maintenance hemodialysis patients. In this study we sought to examine the association of the levels of serum C-reactive protein (CRP) with value of Ca×
Nasri, H.
core +1 more source
The Role of Micronutrients in Atherosclerosis: Mechanisms and Clinical Application
Journal of Cellular and Molecular Medicine, Volume 29, Issue 21, November 2025.ABSTRACT Micronutrients, though required in relatively small quantities by the human body, are essential for maintaining normal physiological functions and play a crucial role in the prevention and management of various diseases. Atherosclerosis (AS) is a common chronic inflammatory condition that often presents without obvious symptoms in its early ...
Yuxin Ouyang +5 more
wiley +1 more source
Linchuang shenzangbing zazhi, 2020 Objective To evaluate the efficacy and safety of ferric citrate in treatment of hyperphosphatemia in patients with chronic kidney disease（CKD）,and provide evidence-based basis for clinical medication.Methods The literature on randomized controlled trials（
WANG Shan-shan, WEN Tong, ZHANG Xin-zhou
doaj
The serum level of the morphogenetic protein fibroblast growth factor 23 (FGF-23) as a marker for the efficiency of hyperphosphatemia therapy with phosphate-binding agents in chronic kidney disease [PDF]
Терапевтический архив, 2016 Aim. To study whether the excessive production of serum fibroblast growth factor 23 (FGF-23) may be reduced with phosphate-binding agents to treat hyperphosphatemia in patients with Stage VD chronic kidney disease (CKD). Subjects and methods.
N A Mukhin +4 more
doaj
71 Analysis From the OPTIMIZE Trial: Evaluating Options for Initiating Tenapanor in CKD Patients on Dialysis With Hyperphosphatemia [PDF]
, 2022 openalex +1 more source
Journal of Small Animal Practice, Volume 66, Issue 11, Page 790-796, November 2025.Objective The objective of the study was to determine the biological variation of select serum biochemistry analytes and fibroblast growth factor 23 in both clinically healthy cats and cats with chronic kidney disease. Methods Eleven healthy cats and seven cats with chronic kidney disease International Renal Interest Society Stages 2 and 3 were ...
S. Summers +3 more
wiley +1 more source
Fibroblast growth factor-23 (FGF-23) / soluble Klotho protein (sKlotho) / sclerostin glycoprotein ratio disturbance is a novel risk factor for cardiovascular complications in ESRD patients receiving treatment with regular hemodialysis or hemodiafiltration [PDF]
Терапевтический архив, 2018 Aim of the study was to explore the role of the FGF-23/sKlotho/sclerostin ratio disturbance in the determining of cardiovascular risk in end stage renal disease (ESRD) patients, receiving treatment with regular hemodialysis (НD) or hemodiafiltration (НDF)
L Yu Milovanova +7 more
doaj +1 more source